Position in GILD
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$3,424,951
-$398,664 QoQ
Shares Held
27,109
-1.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#677
of 2,265 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AdvisorNet Financial, Inc holds $20,577,968 across 14 Drug Manufacturers - General names. GILD ranks #2 (16.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,169 | $3,852,470 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
27,109 | $3,424,951 | |
| 3 | LLY |
ELI LILLY & Co
|
2,556 | $3,065,743 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
38,342 | $2,209,266 | |
| 5 | AZN |
Astrazeneca PLC
|
11,574 | $2,194,661 | |
| 6 | ABBV |
AbbVie Inc.
|
6,595 | $1,659,565 | |
| 7 | MRK |
Merck & Co., Inc.
|
10,405 | $1,337,042 | |
| 8 | GSK |
GSK plc
|
17,988 | $942,930 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,424,951 | 27,109 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $3,823,615 | 27,435 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $3,500,299 | 28,518 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $3,215,892 | 28,972 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $3,270,332 | 29,497 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $3,337,521 | 29,786 | Shares | Sole | 2025-04-07 | |
| 2024-12-31 | $2,837,698 | 30,721 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $2,603,818 | 31,057 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $2,339,944 | 34,105 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $2,785,990 | 38,034 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $4,434,082 | 54,735 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $4,099,442 | 54,703 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $4,414,107 | 57,274 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $4,742,565 | 57,160 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $4,934,658 | 57,480 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $3,585,052 | 58,114 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $3,565,386 | 57,683 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $3,442,095 | 57,899 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $3,371,790 | 46,437 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $2,993,421 | 42,855 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $2,906,649 | 42,211 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $2,656,551 | 41,104 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $2,244,932 | 38,533 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $2,500,491 | 39,571 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $1,882,721 | 24,470 | Shares | Sole | 2020-08-26 | |
| 2020-03-31 | $731,975 | 9,791 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||